Detailed Mechanism Funding and Narrative

Years of mechanism: 2015 2016 2017 2018 2019 2020

Details for Mechanism ID: 18025
Country/Region: Malawi
Year: 2017
Main Partner: Lighthouse Trust
Main Partner Program: NA
Organizational Type: NGO
Funding Agency: HHS/CDC
Total Funding: $4,760,609 Additional Pipeline Funding: $300,000

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $95,212
Care: TB/HIV (HVTB) $285,637
Care: Pediatric Care and Support (PDCS) $238,030
Sexual Prevention: Abstinence/Be Faithful (HVAB) $142,818
Testing: HIV Testing and Counseling (HVCT) $238,030
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $190,424
Treatment: Adult Treatment (HTXS) $2,380,306
Treatment: Pediatric Treatment (PDTX) $1,190,152
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2018 368,865
HTS_TST Service Delivery Point (Facility) ANC: 10-14, Negative 2018 194
HTS_TST Service Delivery Point (Facility) ANC: 15-19, Negative 2018 13,199
HTS_TST Service Delivery Point (Facility) ANC: 20-24, Negative 2018 20,247
HTS_TST Service Delivery Point (Facility) ANC: 25-49, Negative 2018 26,971
HTS_TST Service Delivery Point (Facility) ANC: 50+, Negative 2018 129
HTS_TST Service Delivery Point (Facility) Index: <1, Negative 2018 1,691
HTS_TST Service Delivery Point (Facility) Index: 1-9, Negative 2018 13,500
HTS_TST Service Delivery Point (Facility) Index: 10-14, Female, Negative 2018 2,940
HTS_TST Service Delivery Point (Facility) Index: 10-14, Male, Negative 2018 2,852
HTS_TST Service Delivery Point (Facility) Index: 15-19, Female, Negative 2018 4,542
HTS_TST Service Delivery Point (Facility) Index: 15-19, Male, Negative 2018 5,269
HTS_TST Service Delivery Point (Facility) Index: 20-24, Female, Negative 2018 4,542
HTS_TST Service Delivery Point (Facility) Index: 20-24, Male, Negative 2018 5,269
HTS_TST Service Delivery Point (Facility) Index: 25-49, Female, Negative 2018 21,998
HTS_TST Service Delivery Point (Facility) Index: 25-49, Male, Negative 2018 23,688
HTS_TST Service Delivery Point (Facility) Index: 50+, Female, Negative 2018 217
HTS_TST Service Delivery Point (Facility) Inpatient: <1, Negative 2018 724
HTS_TST Service Delivery Point (Facility) Inpatient: 1-9, Negative 2018 5,762
HTS_TST Service Delivery Point (Facility) Inpatient: 10-14, Female, Negative 2018 1,257
HTS_TST Service Delivery Point (Facility) Inpatient: 10-14, Male, Negative 2018 1,215
HTS_TST Service Delivery Point (Facility) Inpatient: 15-19, Female, Negative 2018 621
HTS_TST Service Delivery Point (Facility) Inpatient: 15-19, Male, Negative 2018 860
HTS_TST Service Delivery Point (Facility) Inpatient: 20-24, Female, Negative 2018 621
HTS_TST Service Delivery Point (Facility) Inpatient: 20-24, Male, Negative 2018 860
HTS_TST Service Delivery Point (Facility) Inpatient: 25-49, Female, Negative 2018 2,121
HTS_TST Service Delivery Point (Facility) Inpatient: 25-49, Male, Negative 2018 2,577
HTS_TST Service Delivery Point (Facility) Inpatient: 50+, Female, Negative 2018 16
HTS_TST Service Delivery Point (Facility) Inpatient: 50+, Male, Negative 2018 131
HTS_TST Service Delivery Point (Facility) Other PITC: 1-9, Negative 2018 666
HTS_TST Service Delivery Point (Facility) Other PITC: 10-14, Female, Negative 2018 143
HTS_TST Service Delivery Point (Facility) Other PITC: 10-14, Male, Negative 2018 140
HTS_TST Service Delivery Point (Facility) Other PITC: 15-19, Female, Negative 2018 898
HTS_TST Service Delivery Point (Facility) Other PITC: 15-19, Male, Negative 2018 4,257
HTS_TST Service Delivery Point (Facility) Other PITC: 20-24, Female, Negative 2018 898
HTS_TST Service Delivery Point (Facility) Other PITC: 20-24, Male, Negative 2018 4,257
HTS_TST Service Delivery Point (Facility) Other PITC: 25-49, Female, Negative 2018 2,685
HTS_TST Service Delivery Point (Facility) Other PITC: 25-49, Male, Negative 2018 5,937
HTS_TST Service Delivery Point (Facility) Other PITC: 50+, Female, Negative 2018 23
HTS_TST Service Delivery Point (Facility) Other PITC: 50+, Male, Negative 2018 313
HTS_TST Service Delivery Point (Facility) TB: <1, Negative 2018 69
HTS_TST Service Delivery Point (Facility) TB: 1-9, Negative 2018 542
HTS_TST Service Delivery Point (Facility) TB: 10-14, Female, Negative 2018 117
HTS_TST Service Delivery Point (Facility) TB: 10-14, Male, Negative 2018 112
HTS_TST Service Delivery Point (Facility) TB: 15-19, Female, Negative 2018 631
HTS_TST Service Delivery Point (Facility) TB: 15-19, Male, Negative 2018 1,942
HTS_TST Service Delivery Point (Facility) TB: 20-24, Female, Negative 2018 631
HTS_TST Service Delivery Point (Facility) TB: 20-24, Male, Negative 2018 1,942
HTS_TST Service Delivery Point (Facility) TB: 25-49, Female, Negative 2018 3,898
HTS_TST Service Delivery Point (Facility) TB: 25-49, Male, Negative 2018 6,129
HTS_TST Service Delivery Point (Facility) TB: 50+, Female, Negative 2018 39
HTS_TST Service Delivery Point (Facility) TB: 50+, Male, Negative 2018 324
HTS_TST Service Delivery Point (Facility) VCT: <1, Negative 2018 83
HTS_TST Service Delivery Point (Facility) VCT: 1-9, Negative 2018 689
HTS_TST Service Delivery Point (Facility) VCT: 10-14, Female, Negative 2018 152
HTS_TST Service Delivery Point (Facility) VCT: 10-14, Male, Negative 2018 146
HTS_TST Service Delivery Point (Facility) VCT: 15-19, Female, Negative 2018 11,556
HTS_TST Service Delivery Point (Facility) VCT: 15-19, Male, Negative 2018 15,977
HTS_TST Service Delivery Point (Facility) VCT: 20-24, Female, Negative 2018 11,556
HTS_TST Service Delivery Point (Facility) VCT: 20-24, Male, Negative 2018 15,977
HTS_TST Service Delivery Point (Facility) VCT: 25-49, Female, Negative 2018 28,470
HTS_TST Service Delivery Point (Facility) VCT: 25-49, Male, Negative 2018 55,085
HTS_TST Service Delivery Point (Facility) VCT: 50+, Female, Negative 2018 287
HTS_TST Service Delivery Point (Facility) VCT: 50+, Male, Negative 2018 2,897
HTS_TST Service Delivery Point (Facility) VMMC: 15-19, Negative 2018 373
HTS_TST Service Delivery Point (Facility) VMMC: 20-24, Negative 2018 373
HTS_TST Service Delivery Point (Facility) VMMC: 25-49, Negative 2018 3,891
HTS_TST Service Delivery Point (Facility) VMMC: 50+, Negative 2018 205
HTS_TST Service Delivery Point (Facility)Other PITC: <1, Negative 2018 81
HTS_TST Sum of Test Result disaggregates 2018 23,193
HTS_TST_POS By Test Result: Positive 2018 23,193
HTS_TST_POS Service Delivery Point (Facility) ANC: 15-19, Positive 2018 200
HTS_TST_POS Service Delivery Point (Facility) ANC: 20-24, Positive 2018 565
HTS_TST_POS Service Delivery Point (Facility) ANC: 25-49, Positive 2018 1,247
HTS_TST_POS Service Delivery Point (Facility) Index: <1, Positive 2018 99
HTS_TST_POS Service Delivery Point (Facility) Index: 1-9, Positive 2018 812
HTS_TST_POS Service Delivery Point (Facility) Index: 10-14, Female, Positive 2018 177
HTS_TST_POS Service Delivery Point (Facility) Index: 10-14, Male, Positive 2018 172
HTS_TST_POS Service Delivery Point (Facility) Index: 15-19, Female, Positive 2018 343
HTS_TST_POS Service Delivery Point (Facility) Index: 15-19, Male, Positive 2018 366
HTS_TST_POS Service Delivery Point (Facility) Index: 20-24, Female, Positive 2018 343
HTS_TST_POS Service Delivery Point (Facility) Index: 20-24, Male, Positive 2018 366
HTS_TST_POS Service Delivery Point (Facility) Index: 25-49, Female, Positive 2018 1,594
HTS_TST_POS Service Delivery Point (Facility) Index: 25-49, Male, Positive 2018 1,821
HTS_TST_POS Service Delivery Point (Facility) Index: 50+, Female, Positive 2018 12
HTS_TST_POS Service Delivery Point (Facility) Inpatient: <1, Positive 2018 58
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 1-9, Positive 2018 497
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 10-14, Female, Positive 2018 101
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 10-14, Male, Positive 2018 97
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 15-19, Female, Positive 2018 56
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 15-19, Male, Positive 2018 70
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 20-24, Female, Positive 2018 56
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 20-24, Male, Positive 2018 70
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 25-49, Female, Positive 2018 206
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 25-49, Male, Positive 2018 249
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 50+, Female, Positive 2018 1
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 50+, Male, Positive 2018 9
HTS_TST_POS Service Delivery Point (Facility) Other PITC: <1, Positive 2018 3
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 1-9, Positive 2018 42
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 10-14, Female, Positive 2018 4
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 10-14, Male, Positive 2018 4
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 15-19, Female, Positive 2018 68
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 15-19, Male, Positive 2018 327
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 20-24, Female, Positive 2018 68
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 20-24, Male, Positive 2018 327
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 25-49, Female, Positive 2018 215
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 25-49, Male, Positive 2018 483
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 50+, Female, Positive 2018 1
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 50+, Male, Positive 2018 21
HTS_TST_POS Service Delivery Point (Facility) TB: <1, Positive 2018 2
HTS_TST_POS Service Delivery Point (Facility) TB: 1-9, Positive 2018 35
HTS_TST_POS Service Delivery Point (Facility) TB: 10-14, Female, Positive 2018 5
HTS_TST_POS Service Delivery Point (Facility) TB: 10-14, Male, Positive 2018 5
HTS_TST_POS Service Delivery Point (Facility) TB: 15-19, Female, Positive 2018 44
HTS_TST_POS Service Delivery Point (Facility) TB: 15-19, Male, Positive 2018 134
HTS_TST_POS Service Delivery Point (Facility) TB: 20-24, Female, Positive 2018 44
HTS_TST_POS Service Delivery Point (Facility) TB: 20-24, Male, Positive 2018 134
HTS_TST_POS Service Delivery Point (Facility) TB: 25-49, Female, Positive 2018 277
HTS_TST_POS Service Delivery Point (Facility) TB: 25-49, Male, Positive 2018 490
HTS_TST_POS Service Delivery Point (Facility) TB: 50+, Female, Positive 2018 1
HTS_TST_POS Service Delivery Point (Facility) TB: 50+, Male, Positive 2018 22
HTS_TST_POS Service Delivery Point (Facility) VCT: <1, Positive 2018 3
HTS_TST_POS Service Delivery Point (Facility) VCT: 1-9, Positive 2018 45
HTS_TST_POS Service Delivery Point (Facility) VCT: 10-14, Female, Positive 2018 5
HTS_TST_POS Service Delivery Point (Facility) VCT: 10-14, Male, Positive 2018 4
HTS_TST_POS Service Delivery Point (Facility) VCT: 15-19, Female, Positive 2018 894
HTS_TST_POS Service Delivery Point (Facility) VCT: 15-19, Male, Positive 2018 1,168
HTS_TST_POS Service Delivery Point (Facility) VCT: 20-24, Female, Positive 2018 894
HTS_TST_POS Service Delivery Point (Facility) VCT: 20-24, Male, Positive 2018 1,168
HTS_TST_POS Service Delivery Point (Facility) VCT: 25-49, Female, Positive 2018 2,288
HTS_TST_POS Service Delivery Point (Facility) VCT: 25-49, Male, Positive 2018 4,051
HTS_TST_POS Service Delivery Point (Facility) VCT: 50+, Female, Positive 2018 20
HTS_TST_POS Service Delivery Point (Facility) VCT: 50+, Male, Positive 2018 214
HTS_TST_POS Service Delivery Point (Facility) VMMC: 15-19, Positive 2018 8
HTS_TST_POS Service Delivery Point (Facility) VMMC: 20-24, Positive 2018 8
HTS_TST_POS Service Delivery Point (Facility) VMMC: 25-49, Positive 2018 70
HTS_TST_POS Service Delivery Point (Facility) VMMC: 50+, Positive 2018 4
PMTCT_ART Already on ART at beginning of current pregnancy 2018 1,305
PMTCT_ART New on ART 2018 1,423
PMTCT_ART Number of HIV-positive pregnant women who received ART to reduce risk of mother-to-child-transmission (MTCT) during pregnancy 2018 2,728
PMTCT_ART Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2018 56,449
PMTCT_EID Number of infants who had a virologic HIV test within 12 months of birth during the reporting period 2018 2,730
PMTCT_EID Number of infants with a negative virological test result between 2 and 12 months of birth 2018 1,427
PMTCT_EID Number of infants with a negative virological test result within 2 months of birth 2018 1,231
PMTCT_EID Number of infants with a positive virological test result between 2 and 12 months of birth 2018 45
PMTCT_EID Number of infants with a positive virological test result within 2 months of birth 2018 27
PMTCT_STAT By Age (Numerator): 10-14 2018 169
PMTCT_STAT By Age (Numerator): 15-19 2018 11,859
PMTCT_STAT By Age (Numerator): 20-24 2018 18,630
PMTCT_STAT By Age (Numerator): 25-49 2018 25,679
PMTCT_STAT By Age (Numerator): 50+ 2018 112
PMTCT_STAT By Number of known positives: 15-19 2018 145
PMTCT_STAT By Number of known positives: 20-24 2018 420
PMTCT_STAT By Number of known positives: 25-49 2018 927
PMTCT_STAT By Number of new negative: 10-14 2018 169
PMTCT_STAT By Number of new negative: 15-19 2018 11,564
PMTCT_STAT By Number of new negative: 20-24 2018 17,819
PMTCT_STAT By Number of new negative: 25-49 2018 23,877
PMTCT_STAT By Number of new negative: 50+ 2018 112
PMTCT_STAT By Number of new positives: 15-19 2018 140
PMTCT_STAT By Number of new positives: 20-24 2018 398
PMTCT_STAT By Number of new positives: 25-49 2018 878
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2018 56,449
PMTCT_STAT_den By Age (Denominator): <15-19 2018 12,481
PMTCT_STAT_den By Age (Denominator): 10-14 2018 178
PMTCT_STAT_den By Age (Denominator): 20-24 2018 19,608
PMTCT_STAT_den By Age (Denominator): 25-49 2018 27,033
PMTCT_STAT_den By Age (Denominator): 50+ 2018 119
PP_PREV Age/sex: 15-19 Female 2018 708
PP_PREV Age/sex: 20-24 Female 2018 180
PP_PREV Age/sex: 20-24 Male 2018 4,302
PP_PREV Age/sex: 25-49 Female 2018 1,526
PP_PREV Age/sex: 25-49 Male 2018 724
PP_PREV Age/sex: 50+ Female 2018 261
PP_PREV Age/sex: 50+ Male 2018 106
PP_PREV Number of the target population who completed a standardized HIV prevention intervention including the minimum components during the reporting period 2018 7,807
PP_PREV Sum of Age/Sex disaggregates 2018 7,807
TB_ART Aggregated Age/Sex: Female <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 97
TB_ART Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 107
TB_ART Aggregated Age/Sex: Male <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 1,219
TB_ART Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 637
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2018 2,150
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2018 2,060
TB_ART_den Aggregated Age/Sex: Female <15 (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 101
TB_ART_den Aggregated Age/Sex: Female 15+ (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 112
TB_ART_den Aggregated Age/Sex: Male <15 (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 1,270
TB_ART_den Aggregated Age/Sex: Male 15+ (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 667
TB_PREV By Age/Sex (Numerator): <15, Female 2018 1,052
TB_PREV By Age/Sex (Numerator): <15, Male 2018 990
TB_PREV By Age/Sex (Numerator): 15+, Female 2018 19,008
TB_PREV By Age/Sex (Numerator): 15+, Male 2018 10,552
TB_PREV By Therapy type (Numerator): Continuous IPT 2018 31,602
TB_PREV The number of ART patients who completed a course of TB preventive therapy or at least 6 months of Isoniazid Preventive Therapy (IPT) during the reporting period 2018 31,602
TB_PREV The number of ART patients who were newly started on TB preventive therapy (including those who newly started on TB preventive therapy in this reporting period and those who started in the previous reporting period but had not been reported as they did not fulfill the minimum requirements for the previous reporting period) 2018 32,573
TB_PREV_den By Age/Sex (Denominator): <15, Female 2018 1,084
TB_PREV_den By Age/Sex (Denominator): <15, Male 2018 1,020
TB_PREV_den By Age/Sex (Denominator): 15+, Female 2018 19,595
TB_PREV_den By Age/Sex (Denominator): 15+, Male 2018 10,874
TB_PREV_den By Therapy type (Denominator): Continuous IPT 2018 32,573
TB_STAT Aggregated Age/Sex: Female <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 162
TB_STAT Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 1,068
TB_STAT Aggregated Age/Sex: Male <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 162
TB_STAT Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 2,240
TB_STAT Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2018 3,632
TB_STAT Total number of registered new and relapsed TB cases, during the reporting period 2018 3,869
TB_STAT_den Aggregated Age/Sex: Female <15 (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 173
TB_STAT_den Aggregated Age/Sex: Female 15+ (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 1,133
TB_STAT_den Aggregated Age/Sex: Male <15 (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 173
TB_STAT_den Aggregated Age/Sex: Male 15+ (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 2,390
TX_CURR Age/Sex: <1 2018 1,069
TX_CURR Age/Sex: <1-9 2018 5,378
TX_CURR Age/Sex: 10-14 Female 2018 778
TX_CURR Age/Sex: 10-14 Male 2018 755
TX_CURR Age/Sex: 15-19 Female 2018 2,421
TX_CURR Age/Sex: 15-19 Male 2018 1,286
TX_CURR Age/Sex: 20-24 Female 2018 3,095
TX_CURR Age/Sex: 20-24 Male 2018 1,286
TX_CURR Age/Sex: 25-49 Female 2018 43,966
TX_CURR Age/Sex: 25-49 Male 2018 27,869
TX_CURR Age/Sex: 50+ Female 2018 356
TX_CURR Age/Sex: 50+ Male 2018 1,467
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2018 89,726
TX_CURR Sum of age/sex disaggregates 2018 3,707
TX_NEW Breastfeeding status 2018 1,080
TX_NEW By Age/Sex: <1 2018 68
TX_NEW By Age/Sex: 1-9 2018 1,100
TX_NEW By Age/Sex: 10-14 Female 2018 151
TX_NEW By Age/Sex: 10-14 Male 2018 139
TX_NEW By Age/Sex: 15-19 Female 2018 1,418
TX_NEW By Age/Sex: 15-19 Male 2018 2,218
TX_NEW By Age/Sex: 20-24 Female 2018 1,879
TX_NEW By Age/Sex: 20-24 Male 2018 2,218
TX_NEW By Age/Sex: 25-49 Female 2018 4,316
TX_NEW By Age/Sex: 25-49 Male 2018 4,737
TX_NEW By Age/Sex: 50+ Female 2018 33
TX_NEW By Age/Sex: 50+ Male 2018 250
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2018 18,534
TX_NEW Pregnancy status 2018 3,990
TX_NEW Sum of Age/Sex disaggregates 2018 17,359
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2018 48,672
TX_PVLS Number of adults and pediatric patients on ART with suppressed viral load results (<1,000 copies/ml) documented in the medical records and /or supporting laboratory results within the past 12 months 2018 43,806
TX_PVLS Numerator: Aggregate Age/Sex by Indication: <15 Female Routine 2018 1,107
TX_PVLS Numerator: Aggregate Age/Sex by Indication: <15 Female Targeted 2018 26
TX_PVLS Numerator: Aggregate Age/Sex by Indication: <15 Male Routine 2018 1,107
TX_PVLS Numerator: Aggregate Age/Sex by Indication: <15 Male Targeted 2018 26
TX_PVLS Numerator: Aggregate Age/Sex by Indication: 15+ Female Routine 2018 26,162
TX_PVLS Numerator: Aggregate Age/Sex by Indication: 15+ Female Targeted 2018 788
TX_PVLS Numerator: Aggregate Age/Sex by Indication: 15+ Male Routine 2018 14,156
TX_PVLS Numerator: Aggregate Age/Sex by Indication: 15+ Male Targeted 2018 434
TX_PVLS Numerator: Indication: Routine 2018 42,531
TX_PVLS Numerator: Indication: Targeted 2018 1,275
TX_PVLS Numerator: Preg/BF by Indication: Breastfeeding Routine 2018 5,447
TX_PVLS Numerator: Preg/BF by Indication: Breastfeeding Targeted 2018 165
TX_PVLS Numerator: Preg/BF by Indication: Pregnant Routine 2018 5,447
TX_PVLS Numerator: Preg/BF by Indication: Pregnant Targeted 2018 165
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Female Routine 2018 1,229
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Female Targeted 2018 29
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Male Routine 2018 1,229
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Male Targeted 2018 29
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Female Routine 2018 29,067
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Female Targeted 2018 872
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Male Routine 2018 15,732
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Male Targeted 2018 485
TX_PVLS_den Denominator: Indication: Routine 2018 47,256
TX_PVLS_den Denominator: Indication: Targeted 2018 1,416
TX_PVLS_den Denominator: Preg/BF by Indication: Breastfeeding Routine 2018 6,048
TX_PVLS_den Denominator: Preg/BF by Indication: Breastfeeding Targeted 2018 183
TX_PVLS_den Denominator: Preg/BF by Indication: Pregnant Routine 2018 6,048
TX_PVLS_den Denominator: Preg/BF by Indication: Pregnant Targeted 2018 183
TX_RET Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 590
TX_RET Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 590
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 11,780
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 5,993
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2018 18,953
TX_RET Numerator by Status: Breastfeeding 2018 592
TX_RET Numerator by Status: Pregnant 2018 312
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2018 25,885
TX_RET_den Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 912
TX_RET_den Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 912
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 15,958
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 8,103
TX_RET_den Denominator by Status: Breastfeeding 2018 734
TX_RET_den Denominator by Status: Pregnant 2018 392
TX_TB Number of ART patients who were screened for TB at least once during the reporting period 2018 77,752
TX_TB Number of ART patients who were started on TB treatment during the reporting period 2018 795
TX_TB Numerator: By Aggregated Age/Sex: <15, Female 2018 27
TX_TB Numerator: By Aggregated Age/Sex: <15, Male 2018 27
TX_TB Numerator: By Aggregated Age/Sex: 15+, Female 2018 482
TX_TB Numerator: By Aggregated Age/Sex: 15+, Male 2018 258
TX_TB_den Denominator: By Aggregated Age/Sex: <15, Female 2018 3,440
TX_TB_den Denominator: By Aggregated Age/Sex: <15, Male 2018 3,440
TX_TB_den Denominator: By Aggregated Age/Sex:15+, Female 2018 45,673
TX_TB_den Denominator: By Aggregated Age/Sex:15+, Male 2018 25,198
TX_TB_den Denominator: By Diagnostic Test [Subdisagg of Specimen Sent]: Gene Xpert MTB / R if Assay 2018 623
TX_TB_den Denominator: By Diagnostic Test [Subdisagg of Specimen Sent]: Other (No Xpert) 2018 25
TX_TB_den Denominator: By Diagnostic Test [Subdisagg of Specimen Sent]: Smear Only 2018 2,461
TX_TB_den Denominator: By Screen Result: Negative 2018 73,144
TX_TB_den Denominator: By Screen Result: Positive 2018 2,972
TX_TB_den Denominator: Number of ART patients who had a specimen sent for bacteriologic diagnosis of active TB disease 2018 3,010
Cross Cutting Budget Categories and Known Amounts Total: $1,188,800
Key Populations: Sex Workers $6,900
Training of health workers and community outreach workers
Key Populations: MSM and TG $6,900
Renovation $100,000
Motor Vehicles: Purchased $625,000
Human Resources for Health $450,000